Clinical Trials Directory

Trials / Unknown

UnknownNCT05284929

Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population

Increased Frequencies of Certain HLA Class II Alleles DRB1 and DQB1 in PV Patients Compared to Those in Healthy Donors Have Been Reported in Various Populations and Repeatedly Confirmed. Among the Russian Population, no Studies About the Association of PV and HLA Class II Genes Have Been Conducted. Thus, the Purpose of This Study Was to Investigate HLA Class II Alleles and Haplotypes in Russian Patients With Pemphigus Vulgaris.

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Sechenov University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Pemphigus is a rare autoimmune life-threatening blistering condition affecting skin and mucous membranes. Pemphigus belongs to a family of polygenic disorders. Several different genes encoding molecules regulate pemphigus autoimmunity. Many trials focused on HLA investigation. Increased levels of certain HLA class II alleles frequencies in pemphigus have been reported in various populations. However, they were not investigated in the Russian population. The aim of our study is to investigate HLA class II alleles and haplotypes in Russian patients with pemphigus. Methods Patients and controls We are recruiting 120 patients with pemphigus. The diagnosis was based on clinical and histopathological findings and confirmed by immunofluorescent techniques (direct and indirect immunofluorescent tests). Before sampling, written consent was obtained from each subject. A single blood sample for HLA typing was obtained from all subjects. This study has been approved by the Ethics Committee of Sechenov University, Russia. Phenotypic and allelic frequencies were compared with healthy blood donors (n=100) registered in Sechenov University blood center.

Conditions

Interventions

TypeNameDescription
GENETICA single blood sample for HLA typingExtracting of DNA from the blood sample using PCR-reaction

Timeline

Start date
2017-05-17
Primary completion
2022-11-17
Completion
2023-03-17
First posted
2022-03-17
Last updated
2022-03-17

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05284929. Inclusion in this directory is not an endorsement.